Orchestra BioMed Holdings, Inc.
OBIO
$4.86
-$0.13-2.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.83M | -19.36M | -18.76M | -16.16M | -15.43M |
| Total Depreciation and Amortization | 81.00K | 81.00K | 83.00K | 84.00K | 76.00K |
| Total Amortization of Deferred Charges | 59.00K | 46.00K | 46.00K | 31.00K | -- |
| Total Other Non-Cash Items | 3.60M | 3.35M | 3.00M | 3.87M | 2.29M |
| Change in Net Operating Assets | 2.54M | 358.00K | -990.00K | -1.36M | -639.00K |
| Cash from Operations | -14.55M | -15.53M | -16.62M | -13.54M | -13.70M |
| Capital Expenditure | -310.00K | -34.00K | -112.00K | -106.00K | -68.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -602.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -38.27M | 16.39M | 13.11M | -3.05M | 625.00K |
| Cash from Investing | -38.58M | 16.36M | 13.00M | -3.75M | 557.00K |
| Total Debt Issued | 20.00M | -- | -- | 15.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 57.78M | 0.00 | 91.00K | 51.00K | 15.04M |
| Repurchase of Common Stock | -269.00K | -428.00K | -387.00K | -550.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.11M | -- | -- | -554.00K | -- |
| Cash from Financing | 76.40M | -428.00K | -296.00K | 13.95M | 15.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.26M | 401.00K | -3.91M | -3.34M | 1.89M |